Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing anti-STa antibodies

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1823-1832

  Ruan, Xiaosai ^a,b   Robertson, Donald C ^b   Nataro, James P ^c   Clements, John D ^d   Zhang, Weiping ^a,b  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; HEAT LABILE TOXIN; NEUTRALIZING ANTIBODY; STA ANTIBODY; STA TOXOID; TOXOID; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUSION GENE; IMMUNIZATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI VACCINES; FECES; FEMALE; IMMUNOGLOBULIN A; MICE; MICE, INBRED BALB C; MUTATION;

EID: 84898892168     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01394-13     Document Type: Article

References (30)

1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969-1987. http://dx.doi.org/10.1016/S0140-6736(10)60549-1.
2. Kotloff KF, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalinam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque ASG, Zaidi AKM, Saha D, Alonso PL, Tamboura B, Sanoo D, Onwuchekwa U, Manna B, Ramamurth T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hassain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and etiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140 -6736(13)60844-2.
3. WHO.2006. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Wkly. Epidemiol. Rec. 81:97-107.
4. WHO. 1999. The World Health Report 1999: making a difference. World Health Organization, Geneva, Switzerland.
5. DuPont HL. 2008. Systematic review: prevention of travellers' diarrhoea. Aliment. Pharmacol. Ther. 27:741-751. http://dx.doi.org/10.1111/j.1365 -2036.2008.03647.x.
6. Sanders JW, Putnam SD, Riddle MS, Tribble DR. 2005. Military importance of diarrhea: lessons from the Middle East. Curr. Opin. Gastroenterol. 21:9-14.
7. Wenneras C, Erling V. 2004. Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J. Health Pop. Nut. 22:370-382.
8. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
9. Berberov EM, Zhou Y, Francis DH, Scott MA, Kachman SD, Moxley RA. 2004. Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins. Infect. Immun. 72: 3914-3424. http://dx.doi.org/10.1128/IAI.72.7.3914-3924.2004.
10. Zhang W, Berberov EM, Freeling J, He D, Moxley RA, Francis DH. 2006. Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity studies. Infect. Immun. 74:3107-3114. http://dx.doi.org/10.1128/IAI.01338-05.
11. Glenn GM, Francis DH, Danielsen EM. 2009. Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines. Infect. Immun. 77:5206-5215. http://dx.doi.org/10.1128/IAI.00712-09.
12. Boedeker EC. 2005. Vaccines for enterotoxigenic Escherichia coli: current status. Curr. Opin. Gastroenterol. 21:15-19.
13. Svennerholm AM. 2011. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Ind. J. Med. Res. 133:188-196.
14. Zhang W, Sack DA. 2012. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans. Expert Rev. Vaccines 11:677-684. http://dx.doi.org/10.1586/erv.12.37.
15. Svennerholm AM, Ahren C, Wenneras C, Holmgren J. 1991. Development of an oral vaccine against enterotoxigenic Escherichia coli diarrhea, p 287-294. In. Wadstrom T, Makela PH, Svennerholm AM, Wolf-Watz H (ed), Molecular pathogenesis of gastrointestinal infections, Plenum Press, London, United Kingdom.
16. Turner AK, Stephens JC, Beavis JC, Greenwood J, Gewert C, Randall R, Freeman D, Darsley MJ. 2011. Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B. Clin. Vaccine Immunol. 18:2128-2135. http://dx.doi.org/10.1128/CVI.05345-11.
17. Clements JD. 1990. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heatstable enterotoxins. Infect. Immun. 1990. 58:1159-1166.
18. Jertborn M, Ahren C, Holmgren J, Svennerholm AM. 1998. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 16:255-260. http://dx.doi.org/10.1016/S0264-410X(97)00169-2.
19. Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P. 2010. Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect. Immun. 78:1824-1831. http://dx.doi.org/10.1128/IAI.01397-09.
20. Svennerholm AM, Holmgren J. 1995. Oral B-subunit whole-cell vaccines against cholera and enterotoxigenic Escherichia coli diarrhoea, p 205-232. In Dlawer A, Ala'Aldeen A, Hormaeche CE (ed), Molecular and clinical aspects of bacterial vaccine development. John Wiley & Sons, Ltd, Chichester, United Kingdom.
21. Zhang W, Zhang C, Francis DH, Fang Y, Knudsen D, Nataro JP, Robertson DC. 2010. Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies. Infect. Immun. 78:316-325. http://dx.doi.org/10.1128/IAI.00497-09.
22. Liu M, Ruan X, Zhang C, Lawson SR, Knudsen DE, Nataro JP, Robertson DC, Zhang W. 2011. Heat-labile-and heat-stable-toxoid fusions (LTR192G-STaP13F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies. Infect. Immun. 79:4002-4009. http://dx.doi.org/10.1128/IAI.00165-11.
23. Liu M, Zhang C, Mateo K, Nataro JP, Robertson DC, Zhang W. 2011. Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G). Toxins (Basel) 3:1146-1162. http://dx.doi.org/10.3390/toxins3091146.
24. Zhang C, Knudsen DE, Liu M, Robertson DC, Zhang W, and the STa Toxoid Vaccine Consortium Group. 2013. Toxicity and immunogenicity of enterotoxigenic Escherichia coli heat-labile and heat-stable toxoid fusion 3xSTaA14Q-LTS63K/R192G/L211A in a murine model. PLoS One 8:e77386. http://dx.doi.org/10.1371/journal.pone.0077386.
25. Norton EB, Lawson LB, Freytag LC, Clements JD. 2011. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin. Vaccine Immunol. 18:546-551. http://dx.doi.org/10.1128/CVI.00538-10.
26. Ausubel FM, Brent R, Kingston RK, Moore DD, Seidman JG, Smith JA, Struhl K. 1999. Short protocols in molecular biology, 4th ed. John Wiley & Sons, Inc, New York, NY.
27. Ruan X, Liu M, Casey TA, Zhang W. 2011. A tripartite fusion, FaeGFedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection. Clin. Vaccine Immunol. 18:1593-1599. http://dx.doi.org/10.1128/CVI.05120-11.
28. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
29. Zhang W, Robertson DC, Zhang C, Bai W, Zhao M, Francis DH. 2008. Escherichia coli constructs expressing human or porcine enterotoxins induce identical diarrheal diseases in a piglet infection model. Appl. Environ. Microbiol. 74:5832-5837. http://dx.doi.org/10.1128/AEM.00893-08.
30. Sato T, Shimonishi Y. 2004. Structural features of Escherichia coli heatstable enterotoxin that activates membrane-associated guanylyl cyclase. J. Peptide Res. 63:200-206. http://dx.doi.org/10.1111/j.1399-3011.2004.00125.x.